Reliable treatment of COVID-19 in view?
In the time of the Coronavirus pandemic, many Researchers working around the world of reliable methods for the effective diagnosis and treatment of the Virus. Some promising new technologies are on the verge of, to be licensed or patented. What help can we expect?
The researchers from the Purdue University in the USA working hard to bring new solutions for the diagnosis and treatment of the corona virus as soon as possible on the market. Information about the currently in development methods were published in the English scientific journal “ACS Omega”.
Investigation focused on diagnostic and therapeutic aspects
The Coronavirus pandemic spreads throughout the world. Therefore, it is important to bring techniques on the market, which can be used for the diagnosis and treatment of the Virus. The Office of Technology Commercialization Purdue Research Foundation collaborates with researchers throughout the University to various technologies, to patent and to license, which focus on the diagnostic and therapeutic aspects of the treatment of COVID-19.
New rapid detection systems to be developed
Technologies that are currently in development include, for example, processes based on paper and micro-fluidic detection systems, which are cost-effective and portable solutions for the diagnosis of COVID-19 on-site. For more information, read the article: corona viruses in the effluent is undetectable.
Sterilization of surfaces, water and air
The researchers from the Purdue University use their Strengths in areas such as environmental technology, health Sciences and chemistry to create solutions for the diagnosis and treatment of people infected with the novel strain of the Coronavirus. So drugs and vaccines can be developed options for the treatment and prevention. The researchers are also working on technologies that can be used for the sterilization of surfaces, water and air.
Long-term solutions are needed
“I think it is important to know that the Purdue researchers during this pandemic, not only to the thinking Today, but that we offer long-term solutions for tomorrow, so we are prepared better in the future on these kinds of challenges,” said Thomas Sors, Deputy Director of the Purdue Institute of Inflammation, Immunology and Infectious Disease, in a press release.
Solutions from other areas could be applied to COVID-19
It is impressive to see how quickly the researchers to respond to the focus of your work on this current outbreak. Many of them have already developed solutions in related areas that can now be applied directly to COVID-19. The research group is currently looking for partnerships in the industry that support you in the fulfilment of this task. (as)